Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-05-20
2009-02-03
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S333000
Reexamination Certificate
active
07485647
ABSTRACT:
This invention provides 2-aminoquinoline derivatives represented by a general formula [I][in which R1and R2either stand for lower alkyl, lower cycloalkyl, etc., or R1and R2together form an aliphatic nitrogen-containing heterocycle with the nitrogen atom to which they bind; R3, R4, R5, R6and R7stand for hydrogen, lower alkyl, etc.; R8stands for lower alkyl, lower alkyloxy, etc.; and n stands for an integer of 0-4]. The compounds act as melanin concentrating hormone receptor antagonist, and are useful as medicines for central nervous system disorders, cardiovascular disorders and metabolic disorders.
REFERENCES:
patent: 1 285 651 (2003-02-01), None
patent: WO 95/32967 (1995-12-01), None
patent: WO 99/48492 (1999-09-01), None
patent: WO 00/64877 (2000-11-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 02/02744 (2002-01-01), None
patent: WO 03/045313 (2003-06-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Kowalski et al., Exp. Opin. Investig. Drugs, vol. 13 (2004), pp. 1113-1122, “Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity”.
Clark et al., J. Med. Chem., vol. 47 (2004), pp. 3962-3971, “A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor”.
Arienzo et al., Bioorg. & Medicinal Chem. Letters, vol. 14 (2004), pp. 4099-4102, Structure-activity relationshps of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.
Kato et al., Chem. Abstracts, 134:266103, “Preparation of N-tetrahydronapththalenyl carboxamides as melanin concentrating hormone antagonists”, 2001.
Antelman et al., Chem. Abstracts, 91:68543, “The importance of stress in assessing the effects of anorectic drugs”, 1979.
Mueller et al., Chem. Abstracts 138:4532, “Preparation of quinolines as ligands for the neuropeptide Y receptor useful against arthritis, cardiovascular diseases, diabetes, renal failure, eating disordes and obesity” 2002.
Ishihara Akane
Iwaasa Hisashi
Kanatani Akio
Moriya Minoru
Suzuki Takao
Banyu Pharmaceutical Co. Ltd.
Fair Janet E.
Fitch Catherine D.
Rao Deepak
LandOfFree
2-aminoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aminoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4103675